Výsledky vyhledávání - "Andrew Hantel"

Akademický článek

Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia

Autor: Andrew Hantel, Colin Cernik, Hajime Uno, Thomas P. Walsh, Gregory S. Calip, Daniel J. DeAngelo, Christopher S. Lathan, Gregory A. Abel

Publikováno v: Blood Cancer Journal, Vol 13, Iss 1, Pp 1-6 (2023)

Abstract Inequitable uptake of novel therapies (NT) in non-cancer settings are known for patients with lower socioeconomic status (SES), People of Color (POC), and older adults. NT uptake equity in acute myeloid leukemia (AML) is not well known. We p

Externí odkaz: https://doaj.org/article/9b37f140e5da4e8198ca83784f2b0eac

Zobrazit plný text záznamu

Akademický článek

Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia

Autor: Andrew Hantel, Marlise R. Luskin, Irum Khan, Elizabeth Warner, Anand A. Patel, Thomas P. Walsh, Daniel J. DeAngelo, Christopher S. Lathan, Gregory A. Abel

Publikováno v: Haematologica, Vol 109, Iss 4 (2023)

Clinical trial eligibility criteria can unfairly exclude patients or unnecessarily expose them to known risks if criteria are not concordant with drug safety. There are few data evaluating the extent to which acute leukemia eligibility criteria are j

Externí odkaz: https://doaj.org/article/a0ceeb90c677488c93614d2865e7474f

Zobrazit plný text záznamu

Akademický článek

Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab

Autor: Andrew Hantel, Brooke Gabster, Jason X. Cheng, Harvey Golomb, Thomas F. Gajewski

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-7 (2018)

Abstract Background Treatment of metastatic melanoma patients with immune checkpoint inhibitors is an important standard of care. Side effects are due to immune activation, can affect virtually all organ systems, and are occasionally severe. Although

Externí odkaz: https://doaj.org/article/3968a5cdc5d24957b688e1adc09bcd79

Zobrazit plný text záznamu

Akademický článek

Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.

Autor: Vidya Balagopal, Andrew Hantel, Sabah Kadri, George Steinhardt, Chao Jie Zhen, Wenjun Kang, Pankhuri Wanjari, Lauren L Ritterhouse, Wendy Stock, Jeremy P Segal

Publikováno v: PLoS ONE, Vol 14, Iss 10, p e0224097 (2019)

Improved systems for detection of measurable residual disease (MRD) in acute myeloid leukemia (AML) are urgently needed, however attempts to utilize broad-scale next-generation sequencing (NGS) panels to perform multi-gene surveillance in AML post-in

Externí odkaz: https://doaj.org/article/4e003646ec644bfb9cfe7194a95a5ed0

Zobrazit plný text záznamu

Plný text ve formátu HTML

Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention

Autor: Andrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Wendy Stock, Sawyer Jacobson, Sumithra Mandrekar, Richard A. Larson, Richard M. Stone, Christopher S. Lathan, Daniel J. DeAngelo, John C. Byrd, Gregory A. Abel

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(32)

PURPOSE Representativeness in acute leukemia clinical research is essential for achieving health equity. The National Cancer Institute's mandate for Comprehensive Cancer Centers (CCCs) to define and assume responsibility for cancer control and treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6927344c5258d03ff39cde3bfc109e4
https://pubmed.ncbi.nlm.nih.gov/35696629

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání